A study conducted by researchers from the CUNY Graduate School of Public Health and Health Policy (CUNY SPH) and the Barcelona Institute for Global Health (ISGlobal) sheds light on public trust in ...

SimBioSys®, a pioneering TechBio company at the forefront of digital precision medicine for cancer care, is proud to announce its second FDA 510(k) clearance for TumorSight™ Viz to expand its use by ...

Encompass Health Corp. (NYSE: EHC) today announced preliminary plans to build a freestanding, 50-bed inpatient rehabilitation hospital in the master planned community of Wiregrass Ranch in Wesley ...

All Hands and Hearts (AHAH), a non-profit organization that provides community-inspired, volunteer-powered disaster relief to international communities, has activated a local Disaster Assistance ...

Dr. David Davtyan , a renowned bariatric surgeon in Los Angeles , has been awarded the prestigious title of Fellow of the American Society for Metabolic & Bariatric Surgery ...

Bolt Medical today announced the completion and results of the RESTORE ATK and RESTORE BTK pivotal clinical trials investigating the company's Bolt IVLTM Above the Knee (ATK) and Below the Knee (BTK) ...

Report Metrics Details Base year considered 2023 Forecast Period considered 2024-2029 Base year market size $196.

Most other major health insurance companies in the U.S. now allow members to opt out of mail-order-only delivery of HIV medications as a result of numerous settlements achieved by attorneys for ...

Keeping your blood pressure within acceptable ranges can keep you healthier longer. Levels less than 120/80 mm Hg are optimal. High blood pressure is defined as 130-139 mm Hg systolic pressure (the ...

Following WHO guidelines could save 3,00,000 lives and prevent millions of chronic health cases, says a study in The Lancet ...

Created with DBE pioneer Prof. Yamamoto, Fujifilm’s new DBE endoscope offers precision imaging and patient safety for small bowel diagnosis and treatment.

HuidaGene Therapeutics ("HuidaGene"), a global clinical-stage biotechnology company, announced that the U.S. FDA has cleared its investigational new drug (IND) application for HG202, the world's first ...